Long-term antimicrobial activity: an adhesive that kills bacteria

Introduction

During teaching and research work at the University of Oklahoma College of Dentistry, a group led by Fernando Luis Esteban Florez developed an adhesive resin with long-term antimicrobial activity, aimed at reducing the incidence of secondary caries at restoration margins. Secondary caries remains one of the primary reasons for the replacement of restorations (fillings and crowns) and, according to the authors, leads to tens of millions of restorative interventions annually and significant direct costs for patients.

Methodology

The work was conducted in collaboration with Oak Ridge National Laboratory, utilizing the resources of the Center for Nanophase Materials Sciences and the High Flux Isotope Reactor. Researchers engineered titanium dioxide (TiO₂) nanoparticles to enable their ability to release reactive oxygen species (ROS)—potent antimicrobial agents—within the adhesive matrix, to which bacteria cannot develop resistance. Dispersed in the dental adhesive resin, these particles were uniformly distributed and exhibited potent antibacterial activity without requiring light activation.

Key technical elements of the methodology include controlling particle size and surface functionalization to achieve stable distribution within the polymer matrix, as well as evaluating ROS release and its antimicrobial effect in in vitro models.

Results

The authors describe the resulting material as the world’s first long-term antimicrobial adhesive based on modified TiO₂ nanoparticles. Under experimental conditions, the adhesive demonstrated sustained antimicrobial activity without the need for light activation, while the particles maintained uniform distribution within the resin.

The technology’s potential for reducing the incidence of secondary caries and decreasing the need for restoration replacements is highlighted. Possible extended applications are also being considered: materials for whitening, antimicrobial coatings for medical devices, and coatings for public spaces. The development is patented, and commercialization negotiations are underway.

Relevance to practice

For clinical dentists, the following practical aspects and verification questions are important before implementation:

• Clinical Efficacy: Randomized clinical trials with long-term follow-up are required to confirm the reduction in secondary caries incidence and to evaluate the preservation of marginal adaptation of restorations.
• Impact on Mechanical Properties: Evaluation of the effect of incorporating modified TiO₂ on bond strength, degree of conversion, polymerization shrinkage stress, and the longevity of the restoration-adhesive interface.
• Biocompatibility and Safety: Data on cytotoxicity, periapical and pulpal response, as well as systemic effects from the long-term presence of ROS-generating particles in the polymer matrix are required.
• Application Technique and Compatibility with Clinical Protocols: It is important to understand whether the modified adhesive requires specific etching protocols, dentin/enamel conditioning, polymerization regimens, or has limitations regarding compatibility with certain composites/cements.
• Regulatory and Commercial Aspects: Manufacturer’s confirmation of batch stability, shelf life, and storage conditions; regulatory approval for clinical use.

Expert commentary

The technology utilizing ROS generation within the adhesive appears promising for reducing bacterial colonization at restoration margins and preventing secondary caries. However, in clinical practice, decisive factors will be data on its impact on adhesion and interface longevity, as well as confirmation of the absence of adverse biological effects from long-term contact with dental and periodontal tissues. During the implementation phase, it is advisable to focus on independent clinical trials, publications on the material’s long-term stability, and compatibility with existing restorative systems.

Recommendations for Clinicians

• Monitor publications of clinical studies and meta-analyses on this adhesive.
• Before widespread adoption, demand data on bond strength and biocompatibility for specific clinical situations (inlays, composite restorations, veneered crowns, etc.).
• Assess the risk-benefit ratio for patients with high caries activity and repeated restorations.

In conclusion, the development of the modified TiO₂ adhesive represents a significant scientific and technological advancement with the potential to reduce the burden of secondary caries. However, detailed data on long-term efficacy, safety, and its impact on the mechanical properties of the adhesive system are necessary for clinical acceptance.